Oncospace Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
Oncospace General Information
Description
Developer of a predictive planning platform designed to optimize outcomes through the active collection of shared expertise. The company's platform uses a machine learning model based on clinical treatment plans to derive achievable, best-practice, dosimetric goals for plan optimization and evaluation, enabling patients to use this knowledge to improve the quality and safety of care.
Contact Information
Website
www.oncospace.comCorporate Office
- 1812 Ashland Avenue
- Suite 100K
- Baltimore, MD 21205
- United States
Corporate Office
- 1812 Ashland Avenue
- Suite 100K
- Baltimore, MD 21205
- United States
Oncospace Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 30-Apr-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 29-Nov-2023 | Completed | Generating Revenue | |||
| 5. Grant | 01-Nov-2021 | Completed | Generating Revenue | |||
| 4. Grant | 01-Apr-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Mar-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 15-May-2019 | $900K | $900K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 11-Mar-2019 | Completed | Generating Revenue |
Oncospace Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Oncospace Patents
Oncospace Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022051068-A1 | Machine-learning-driven auto-planning for radiation treatment | Inactive | 04-Sep-2020 |
Oncospace Signals
Oncospace Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abell Foundation | Not-For-Profit Venture Capital | Minority | ||
| Johns Hopkins Technology Ventures | Accelerator/Incubator | Minority | ||
| National Institutes of Health | Government | |||
| US National Science Foundation | Accelerator/Incubator |
Oncospace FAQs
-
When was Oncospace founded?
Oncospace was founded in 2018.
-
Where is Oncospace headquartered?
Oncospace is headquartered in Baltimore, MD.
-
What is the size of Oncospace?
Oncospace has 12 total employees.
-
What industry is Oncospace in?
Oncospace’s primary industry is Outcome Management (Healthcare).
-
Is Oncospace a private or public company?
Oncospace is a Private company.
-
What is Oncospace’s current revenue?
The current revenue for Oncospace is .
-
How much funding has Oncospace raised over time?
Oncospace has raised $4.8M.
-
Who are Oncospace’s investors?
Abell Foundation, Johns Hopkins Technology Ventures, National Institutes of Health, and US National Science Foundation have invested in Oncospace.
-
When was Oncospace acquired?
Oncospace was acquired on 30-Apr-2025.
-
Who acquired Oncospace?
Oncospace was acquired by Sun Nuclear.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process